Corporate Banner
Satellite Banner
Technology Networks Header
Friday, September 19, 2014
Technology Networks
 
Register | Sign in
Home Page
  About Us

Technology Networks

Established since 2000, Technology Networks is a major online publisher focused on delivering relevant information to the life sciences and drug discovery communities.

In addition to this, our main website, we also produce LabTube - the main scientific video site and ePosters, The Online Journal of Scientific Posters.

Our Communities
Agrigenomics Biologics and Bioprocessing
Biomolecular Screening Cell Culture Chemical Process Scale Up
Chromotography Crystallography Environmental Analysis
Food and Beverage Forensic Science & Clinical Toxicology Gene Silencing
Genomics Genotyping and Gene Expression Immunology
Informatics Lab-on-a-Chip
LIMs and ELNs Market Reports Mass Spectrometry
Medicinal Chemistry Metabolomics and Lipidomics Molecular and Clinical Diagnostics
Next Gen Sequencing PharmaOutsourcing Proteomics
qPCR Spectroscopy Stem Cells, Cellular Therapy & Biobanking

Scientific News
Intestinal Bacteria Needed for Strong Flu Vaccine Responses in Mice
Study demonstrate a dependency on gut bacteria for strong immune responses to the seasonal flu and inactivated polio vaccines.
Novel Immunotherapy Breast Cancer Vaccine
Vaccine Decreases Recurrence in HER2 Positive Breast Cancer Patients.
Cell ‘Memory’ Could be Key to Strengthen Vaccine Efficacy
Virginia Tech Carilion Research Institute scientists uncover immune system secret.
NIH-Led Scientists Discover HIV Antibody that Binds to Novel Target on Virus
The antibody, 35O22, prevents 62 percent of known HIV strains from infecting cells in the laboratory.
Breakthrough Melanoma Treatment, Keytruda, Developed
New immunotherapy launched in the US for treatment of adults with advanced melanoma, developed using antibody humanization expertise at UK’s MRC Technology.
Understanding and Improving the Body's Fight Against Pathogens
A*STAR scientists find new targets for modulating antibody response.
NIH to Launch Human Safety Study of Ebola Vaccine Candidate
Trial is First in Series of Accelerated Safety Studies of Ebola Vaccines.
MU Researchers Discover Protein's Ability To Inhibit HIV Release
TIM-family proteins have the ability to block the release of HIV and other viruses.
High Capacity Antibody Purification
Researchers from the A*Star Bioprocessing Technology Institute have used magnetic nanoparticles to break the capacity barrier for antibody purification.
Experimental Chikungunya Vaccine Induces Robust Antibody Response
Vaccine developed by NIH scientists performs well in early clinical trial.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv